A prospective study to validate an algorithm using urine and plasma biomarkers for predicting high-risk prostate cancer on biopsy

Mike Allan Mortensen (Foredragsholder)

Aktivitet: Foredrag og mundtlige bidragKonferenceoplæg

Periode14. jun. 2017
Begivenhedstitel31th Biennial Conference of the Scandinavian Assiciation of Urology
BegivenhedstypeKonference
Konferencenummer31
PlaceringOdense , Danmark
Grad af anerkendelseInternational

Emneord

  • prostata cancer